Retardation of Azo-Carcinogenesis by Non-Carcinogenic Azo-Compounds
1955

Retardation of Azo-Carcinogenesis by Non-Carcinogenic Azo-Compounds

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): H. G. Crabtree

Primary Institution: Imperial Cancer Research Fund

Hypothesis

The potentiality of liberating p-aminobenzoic acid (p-AB) might be a factor determining the genesis of liver tumours.

Conclusion

The study found that certain non-carcinogenic azo-compounds can inhibit the induction of liver tumours caused by carcinogenic azo-compounds.

Supporting Evidence

  • Rats consuming a diet with non-carcinogenic azo-compounds grew more quickly than those on a basic diet alone.
  • Rats on a diet containing a carcinogen progressively lost weight and developed liver tumours.
  • Adding non-carcinogenic azo-compounds to a carcinogenic diet increased the weight of rats and retarded liver tumour incidence.

Takeaway

Some chemicals that don't cause cancer can help stop other chemicals that do cause cancer from making rats sick.

Methodology

Rats were fed a diet containing carcinogenic and non-carcinogenic azo-compounds, and their growth and tumour development were monitored.

Limitations

The study's results may be influenced by intercurrent deaths due to lung infections in the rats.

Participant Demographics

Rats of the Glaxo strain, with males weighing 150-165 g and females 130-140 g.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication